Anti-Mullerian hormone and polycystic ovary syndrome
Igor P. Nikolayenkov, Vladimir Vsevolodovich Potin, Marina A. Tarasova
Abstract
Open-access reader
Igor P. Nikolayenkov, Vladimir Vsevolodovich Potin, Marina A. Tarasova
Abstract
Open-access reader
Polycystic ovary syndrome (PCOS) is the most common form of normogonadotropic ovarian insufficiency, hyperandrogenaemy and anovulation sterility. One of the probable causes of this disease is disturbance of folliculogenesis, which is accompanied by overproduction of anti-Mullerian hormone (AMH) by ovarian tissue. There is a literature review about structure, biological properties and the role of AMH in pathogenesis of PCOS in this article.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Polycystic ovary syndrome (PCOS) is the most common form of normogonadotropic ovarian insufficiency, hyperandrogenaemy and anovulation sterility. One of the probable causes of this disease is disturbance of folliculogenesis, which is accompanied by overproduction of anti-Mullerian hormone (AMH) by ovarian tissue. There is a literature review about structure, biological properties and the role of AMH in pathogenesis of PCOS in this article.
Key concepts: Polycystic ovary, Anovulation, Anti-Müllerian hormone, Medicine, Folliculogenesis, Sterility, Ovary, Endocrinology